Gediz Ambalaj Sanayi ve Ticaret AS

Gediz Ambalaj maintains a strong liquidity position with a current ratio of 3.88, indicating the company can easily cover its short-term obligations. The company's debt-to-equity ratio is 0.03, reflecting a conservative capital structure with minimal leverage. Free cash flow of 41.18 million TRY and operating cash flow of 22.67 million TRY support its liquidity profile. Profitability metrics show a return on equity of 1.52% and a return on assets of 1.03%, which are below the typical thresholds for capital-intensive chemical industries. The net income of 16.36 million TRY on 1.07 billion TRY in revenue suggests a narrow margin profile, consistent with commodity chemical producers. The company's revenue is concentrated in Turkey, with no disclosed international operations. This geographic concentration increases exposure to local economic and regulatory risks, including currency volatility and domestic demand fluctuations. No material segment disclosures are available, but the primary product line is corrugated PP sheets, which are used across multiple industries. Gediz Ambalaj's growth trajectory is constrained by its current financial performance. The company's operating income of 345.02 million TRY and gross profit of 361.18 million TRY indicate stable but modest profitability. No significant revenue growth is projected in the next fiscal year, and capital expenditures are minimal at -26.28 million TRY, suggesting a focus on operational efficiency rather than expansion. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash reserves reduce financial distress risk. However, the narrow net income margin of 1.52% and low ROE suggest vulnerability to cost inflation or margin compression in the plastics industry. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's operations remain focused on its core corrugated PP sheet business, with no disclosed R&D initiatives or new product launches in the latest financial reports.